Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12612001074886Phase 2Completed
Phase 2, open-label trial of levobupivacaine and sevoflurane in postoperative pain (2 arms), sponsored by Yusheng Pharmaceutical. Primary endpoints: Time to first rescue medication and Number of patients not requiring rescue analgesia. Started Oct 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12612001074886.